Solid State Logic announces the latest evolution of its cross-platform Mac and Windows application, which forms the ‘brains’ ...

Invenia-STL Networks, a digital infrastructure and IT services company, has secured a major contract worth over ₹360 crore from PowerGrid Teleservices (PowerTel) – a wholly-owned subsidiary of the ...

Oxford, UK, May 12, 2025 — Solid State Logic continues to expand its powerful lineup of plug-ins and software for its SSL 360° platform, this time announcing its new Meter Pro plug-in whilst also ...

FDA grants full approval to Bayer's Vitrakvi for NTRK fusion-positive solid tumors in adults and children. Clinical trials show a 60% overall response rate and median response duration of 43.3 months ...

VITRAKVI ® is now fully approved for adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation ...

One of the major reasons why using Linux on a desktop system is unsuitable for many is due to the lack of Linux support for many major applications, including Autodesk Fusion 360. Naturally, using ...

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion As the field of DNA and RNA testing advances ...

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion Targeting actionable fusions has emerged as ...

Autodraw Fusion 360 is a cross-platform software that runs mainly on macOS and any Microsoft Windows version except Windows 7. Network connection and hardware compatibility issues can cause Fusion 360 ...

Writer and occasional reluctant perpetrator of engine swaps, James O'Neil is a malaise era enthusiast and also fascinated by the many ways the auto industry has since recovered from those dark days.

Fusion to Host Conference Call Tomorrow, Tuesday, June 27 th at 4:00 p.m. ET/3:00 p.m. CT HAMILTON, ON and BOSTON, June 26, 2023 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage ...